Back to Journals » ImmunoTargets and Therapy » Volume 3

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?

Total article views   HTML views PDF downloads Totals
10,141 Dovepress* 9,599+ 3,208 12,807
PubMed Central* 542 167 709
Totals 10,141 3,375 13,516
*Since 27 December 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar